×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
QNRX – quoin pharmaceuticals, ltd. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
QNRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/20
08:30 am
qnrx
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
Medium
Report
Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome
11/18
01:19 pm
qnrx
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
High
Report
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/12
01:29 pm
qnrx
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/11
09:27 am
qnrx
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies [Yahoo! Finance]
High
Report
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies [Yahoo! Finance]
11/11
08:30 am
qnrx
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
High
Report
Quoin Pharmaceuticals Announces Achievement of Topical Rapamycin Target Loadings for Two Proprietary Delivery Technologies
11/7
01:15 am
qnrx
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Medium
Report
Quoin Pharmaceuticals (NASDAQ:QNRX) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/6
08:30 am
qnrx
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
High
Report
Quoin Pharmaceuticals Announces Corporate Update and Third Quarter 2025 Financial Results
10/30
08:30 am
qnrx
Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Medium
Report
Quoin Pharmaceuticals to Provide Corporate Update and Announce Third Quarter 2025 Financial Results on Thursday, November 6, 2025
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/16
04:04 pm
qnrx
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Stonepine Capital Management, LLC
High
Report
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Stonepine Capital Management, LLC
12/15
09:53 pm
qnrx
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Ikarian Capital, LLC
High
Report
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Ikarian Capital, LLC
12/11
10:10 am
qnrx
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Resolute Capital Asset Partners LLC
Medium
Report
Form SCHEDULE 13G Quoin Pharmaceuticals, Filed by: Resolute Capital Asset Partners LLC
12/5
08:01 am
qnrx
Form 424B3 Quoin Pharmaceuticals,
High
Report
Form 424B3 Quoin Pharmaceuticals,
12/5
06:03 am
qnrx
Form EFFECT Quoin Pharmaceuticals,
High
Report
Form EFFECT Quoin Pharmaceuticals,
12/3
05:39 pm
qnrx
Form 4 Quoin Pharmaceuticals, For: Dec 01 Filed by: Lawlor Sally Bridget
Medium
Report
Form 4 Quoin Pharmaceuticals, For: Dec 01 Filed by: Lawlor Sally Bridget
11/17
05:01 pm
qnrx
Form 8-K Quoin Pharmaceuticals, For: Nov 14
High
Report
Form 8-K Quoin Pharmaceuticals, For: Nov 14
11/12
08:01 am
qnrx
Form 8-K Quoin Pharmaceuticals, For: Nov 11
High
Report
Form 8-K Quoin Pharmaceuticals, For: Nov 11
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: